Literature DB >> 32848191

Melphalan pharmacokinetics and transplant related toxicity during autologous stem cell transplantation.

Ugur Sahin1, Ender Soydan2, Ayla Gokmen2, Muhit Ozcan3, Onder Arslan3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32848191     DOI： 10.1038/s41409-020-01043-6

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  2 in total

1.  Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis.

Authors:  Iuliana Vaxman; M Hasib Sidiqi; Abdullah S Al Saleh; Shaji Kumar; Eli Muchtar; Angela Dispenzieri; Francis Buadi; David Dingli; Martha Lacy; Suzanne Hayman; Nelson Leung; Wilson Gonsalves; Taxiarchis Kourelis; Rahma Warsame; William Hogan; Morie Gertz
Journal:  Bone Marrow Transplant       Date:  2020-11-18       Impact factor: 5.483

Review 2.  High-dose intravenous melphalan: a review.

Authors:  B L Samuels; J D Bitran
Journal:  J Clin Oncol       Date:  1995-07       Impact factor: 44.544
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.